Bibliometric and visualized analysis of the application of nanotechnology in glioma

被引:5
作者
Du, Xue [1 ,2 ]
Chen, Chunbao [2 ]
Yang, Lu [1 ,2 ]
Cui, Yu [1 ,2 ]
Tan, Bangxian [1 ,2 ]
机构
[1] North Sichuan Med Coll, Afliated Hosp, Dept Oncol, Nanchong, Peoples R China
[2] North Sichuan Med Coll, Nanchong, Peoples R China
关键词
bibliometric; glioma; blood-brain barrier; nanotechnology; nanoparticles; drug delivery; BLOOD-BRAIN-BARRIER; DELIVERY; GLIOBLASTOMA; PATTERNS; EFFICACY; SAFETY; TUMORS;
D O I
10.3389/fphar.2022.995512
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Glioma is the most prevalent malignant tumor in the central nervous system (CNS). Due to its highly invasive characteristics and the existence of the blood-brain barrier (BBB), the early diagnosis and treatment of glioma remains a major challenge in cancer. With the flourishing development of nanotechnology, targeted nano-therapy for glioma has become a hot topic of current research by using the characteristics of nanoparticles (NPs), such as it is easier to pass the blood-brain barrier, degradable, and aids controllable release of drugs in the brain. The purpose of this study is to visualize the scientific achievements and research trends of the application of nanotechnology in glioma. Methods: We searched the literature related to glioma nanotechnology on the Web of Science (WOS). The bibliometric and visual analysis was performed mainly using CiteSpace, VOSviewer, and R software, for countries/regions, authors, journals, references, and keywords associated with the field. Results: A total of 3,290 publications from 2012 to June 2022 were searched, and 2,041 works of literature were finally obtained according to the search criteria, the number of publications increasing year by year, with an average growth rate (AGR) of 15.22% from 2012 to 2021. China published 694 (20.99%), followed by the United States (480, 20.70%). The institution with the highest number of publications is Fudan Univ (111, 13.16%), and 80% of the top ten institutions belong to China. HUILE GAO (30) and XINGUO JIANG (30) both published the largest number of research studies. STUPP R (412) was the most cited author, followed by GAO HL (224). The degree of collaboration (DC) among countries/regions, research institutions, and authors is 23.37%, 86.23%, and 99.22%, respectively. International Journal of Nanomedicine published the largest number of publications (81), followed by Biomaterials (73). Biomaterials (1,420) was the most cited journal, followed by J Control Release (1,300). The high frequency of keywords was drug delivery (487), followed by nanoparticle (450), which indicates that nanoparticles (NPs) as a carrier for drug delivery is a hot topic of current research and a direction of continuous development. Conclusion: In recent years, nanotechnology has attracted much attention in the medical field. Cooperation and communication between countries/regions and institutions need to be strengthened in future research to promote the development of nanomedicine. Nanotherapeutic drug delivery systems (NDDS) can enhance drug penetration and retention in tumor tissues, improve drug targeting, and reduce the toxic side effects of drugs, which has great potential for the treatment of glioma and has become the focus of current research and future research trends in the treatment of glioma.
引用
收藏
页数:13
相关论文
共 61 条
[1]   Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment [J].
Afsharzadeh, Maryam ;
Hashemi, Maryam ;
Mokhtarzadeh, Ahad ;
Abnous, Khalil ;
Ramezani, Mohammad .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (06) :1095-1110
[2]   Nanoparticles in the clinic: An update [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2019, 4 (03)
[3]   Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity [J].
Arias, Lais Salomao ;
Pessan, Juliano Pelim ;
Miranda Vieira, Ana Paula ;
Toito de Lima, Taynara Maria ;
Botazzo Delbem, Alberto Carlos ;
Monteiro, Douglas Roberto .
ANTIBIOTICS-BASEL, 2018, 7 (02)
[4]   Simultaneous Blood-Brain Barrier Crossing and Protection for Stroke Treatment Based on Edaravone-Loaded Ceria Nanoparticles [J].
Bao, Qunqun ;
Hu, Ping ;
Xu, Yingying ;
Cheng, Tiansheng ;
Wei, Chenyang ;
Pan, Limin ;
Shi, Jianlin .
ACS NANO, 2018, 12 (07) :6794-6805
[5]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[6]   Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials [J].
Bruinsmann, Franciele Aline ;
Vaz, Gustavo Richter ;
Soares Alves, Aline de Cristo ;
Aguirre, Tanira ;
Pohlmann, Adriana Raffin ;
Guterres, Silvia Staniscuaski ;
Sonvico, Fabio .
MOLECULES, 2019, 24 (23)
[7]   ALZHEIMER'S DISEASE A breach in the blood-brain barrier [J].
Carmeliet, Peter ;
De Strooper, Bart .
NATURE, 2012, 485 (7399) :451-452
[8]   Visualizing a field of research: A methodology of systematic scientometric reviews [J].
Chen, Chaomei ;
Song, Min .
PLOS ONE, 2019, 14 (10)
[9]  
Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006
[10]   Patterns of Connections and Movements in Dual-Map Overlays: A New Method of Publication Portfolio Analysis [J].
Chen, Chaomei ;
Leydesdorff, Loet .
JOURNAL OF THE ASSOCIATION FOR INFORMATION SCIENCE AND TECHNOLOGY, 2014, 65 (02) :334-351